Literature DB >> 17570010

Glycodelin gene expression in human peripheral white blood cells.

E E Lang1, G Venkatraman.   

Abstract

BACKGROUND: Glycodelin plays an important role in normal and abnormal reproductive growth. The in vitro properties of glycodelin have been studied in K562 cells. The role of glycodelin in vivo in the peripheral circulation has not been determined. AIM: To determine if circulating leukocytes in normal subjects express the glycodelin gene, with a view to understanding its contribution to various disease processes.
METHOD: RT-PCR analysis of mononuclear cells isolated from the blood of healthy volunteers was used to show glycodelin mRNA expression. Immunocytostaining was performed using anti-glycodelin antibody.
RESULTS: PCR analysis illustrated the expression of the glycodelin gene in peripheral mononuclear cells. Glycodelin protein in these cells was confirmed with immunostaining.
CONCLUSION: The presence of glycodelin in peripheral white blood cells was demonstrated. The ability of glycodelin to stimulate angiogenesis and act as an immunosuppressive agent could be an indicator of the role of peripheral leukocytes in various disease states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570010     DOI: 10.1007/s11845-007-0019-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Increased glycodelin levels in gynecological malignancies.

Authors:  I R Horowitz; C Cho; M Song; L C Flowers; N Santanam; S Parthasarathy; S Ramachandran
Journal:  Int J Gynecol Cancer       Date:  2001 May-Jun       Impact factor: 3.437

2.  New soluble placental tissue proteins: their isolation, characterization, localization and quantification.

Authors:  H Bohn; W Kraus; W Winckler
Journal:  Placenta Suppl       Date:  1982

Review 3.  Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses.

Authors:  L Lögdberg; L Wester
Journal:  Biochim Biophys Acta       Date:  2000-10-18

4.  Angiogenic role for glycodelin in tumorigenesis.

Authors:  M Song; S Ramaswamy; S Ramachandran; L C Flowers; I R Horowitz; J A Rock; S Parthasarathy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

5.  Generation and characterization of a polyclonal antipeptide antibody to human glycodelin.

Authors:  A S Poddar; J G Kim; K P Gill; B N Bates; N Santanam; J A Rock; A A Murphy; S Parthasarathy
Journal:  Fertil Steril       Date:  1998-03       Impact factor: 7.329

6.  Suppression by human placental protein 14 of natural killer cell activity.

Authors:  N Okamoto; A Uchida; K Takakura; Y Kariya; H Kanzaki; L Riittinen; R Koistinen; M Seppälä; T Mori
Journal:  Am J Reprod Immunol       Date:  1991-12       Impact factor: 3.886

7.  Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage.

Authors:  D M Morrow; N Xiong; R R Getty; M Z Ratajczak; D Morgan; M Seppala; L Riittinen; A M Gewirtz; M L Tykocinski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Placental protein 14 regulates selective B cell responses.

Authors:  Einat Yaniv; Zipora Borovsky; Galit Mishan-Eisenberg; Jacob Rachmilewitz
Journal:  Cell Immunol       Date:  2003-04       Impact factor: 4.868

9.  Placental protein 14 (PP14) content and immunosuppressive activity of human cervical mucus.

Authors:  A G Pockley; C L Barratt; A E Bolton
Journal:  Symp Soc Exp Biol       Date:  1989

10.  Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida.

Authors:  S Oehninger; C C Coddington; G D Hodgen; M Seppala
Journal:  Fertil Steril       Date:  1995-02       Impact factor: 7.329

View more
  1 in total

1.  Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.

Authors:  Christoph Scholz; Sabine Heublein; Miriam Lenhard; Klaus Friese; Doris Mayr; Udo Jeschke
Journal:  BMC Res Notes       Date:  2012-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.